(Q33760507)

29 July 2017

1 reference

title

The past, present and future of antimycotic combination therapy (English)

1 reference

29 July 2017

Polak A

1

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

42

1 reference

29 July 2017

issue

5-6

1 reference

29 July 2017

page(s)

355-370

1 reference

Synergism of Polyene Antibiotics with 5-Fluorocytosine

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Combination therapy for systemic mycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Bone marrow toxicity associated with 5-fluorocytosine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Amphotericin B nephrotoxicity in humans decreased by salt repletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Therapy for cryptococcal meningitis in patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Flucytosine--what is its future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Treatment of opportunistic fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Successful medical treatment of presumed Candida endocarditis in critically ill infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Meningitis caused by Candida species: an emerging problem in neurosurgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Candidal meningitis in HIV-infected patients: analysis of 14 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Successful treatment of fungal prosthetic valve endocarditis: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Antifungal treatment of Candida peritonitis in continuous ambulatory peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Candida endophthalmitis: clinical presentation, treatment and outcome in 23 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Favorable outcome of invasive aspergillosis in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

The future of antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Use of amphotericin B with azole antifungal drugs: what are we doing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Properties of a purified proteinase from the yeast Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

New systematically active antimycotics from the beta-blocker category

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

In vivo activity of interferon-gamma in combination with amphotericin B in the treatment of experimental cryptococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Successful treatment of a Trichosporon beigelii septicemia in a granulocytopenic patient with amphotericin B and granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Bacillary angiomatosis: a role for Phyllobacterium?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Current management of onychomycosis. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00475.X

10.1046/J.1439-0507.1999.00475.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference